{"id":124723,"date":"2024-05-23T13:11:30","date_gmt":"2024-05-23T07:41:30","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=124723"},"modified":"2024-05-23T16:50:17","modified_gmt":"2024-05-23T11:20:17","slug":"what-to-do-with-sun-pharma-shares-post-q4-results-heres-everything-you-need-to-know","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/what-to-do-with-sun-pharma-shares-post-q4-results-heres-everything-you-need-to-know\/","title":{"rendered":"What to do with Sun Pharma shares post Q4 results? Here&#8217;s everything you need to know"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-3466352865\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>The shares of India&#8217;s largest drug manufacturer fell by 4.8% the day after the company announced robust 32% year-on-year growth in net profit.&nbsp;<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-153117459\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><p>At 11:50 a.m., <strong>Sun Pharmaceutical Industries Ltd<\/strong> shares were trading at Rs 1,484 per share, down 3.66% on the National Stock Exchange from the previous close price. The company has a market capitalization of Rs 3,56,052 crore.\u00a0<\/p><p>The company&#8217;s consolidated revenue reached Rs 11,982.9 crore, reflecting a 9% increase from Rs 10,930.6 crore the previous year. Net profit rose by 32%, from Rs 2,016 crore to Rs 2,666 crore, driven by a 62% surge in other income, which amounted to Rs 606 crore compared to Rs 373 crore in the same quarter last year.&nbsp;<\/p><p>Sun Pharma&#8217;s EBITDA margin stood at 25.3%, surpassing the 24.6% estimate by 70 basis points, though it was 30 basis points lower than last year&#8217;s margin.&nbsp;<\/p><div class=\"trade-content_5\" id=\"trade-3483388956\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>India formulation sales for the March quarter grew by 10.2% year-over-year to Rs 3,707 crore, representing 31.4% of the company&#8217;s total consolidated sales.&nbsp;<\/p><p>Sun Pharma\u2019s global specialty sales were reported at US$ 271 million, marking an 11.1% increase year-over-year. For the full fiscal year 2024, formulation sales in emerging markets totaled US$ 1,041 million, a 5.9% rise from the previous year. In Q4FY24, emerging markets sales were US$ 245 million, up 10.8% year-over-year, accounting for 17.2% of the total consolidated sales for the quarter.&nbsp;<\/p><p>For the full year ended March 31, 2024, revenues rose by 20% to Rs 48,496 crores, compared to Rs 43,885 crores for the year ended March 31, 2023. Profit for the full year increased by 13% to Rs 9,640 crores, up from Rs 8,560 crores in the previous year.&nbsp;<\/p><p>The company\u2019s R&amp;D investments during the quarter were Rs 900 crore, compared to Rs 665 crore in the same quarter the previous year. R&amp;D spending was 7.6% of sales in Q4FY24, with specialty R&amp;D constituting 42% of the total R&amp;D expenditure.&nbsp;<\/p><p><strong>CLSA has an &#8216;underperform&#8217; rating on Sun Pharmaceutical Industries stock with a target of Rs 1,610, citing near-term margin pressure and moderate guidance for fiscal 2025.<\/strong><\/p><p><strong>Nuvama has downgraded the stock to \u2018hold\u2019 with a target price of Rs 1,620, based on an earnings miss at the operating level. Following the company\u2019s guidance of high single-digit revenue growth and 8\u201310% R&amp;D spend, the brokerage firm cut its FY25E\/26E EPS by 17%\/6%.&nbsp;<\/strong><\/p><div class=\"trade-content-10\" id=\"trade-2196539739\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_3_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"2969612066\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>However,Jefferies and HSBC have maintained a &#8216;buy&#8217; call on Sun Pharma stock with target prices of Rs 1,785 and Rs 1,670, respectively. Citi has also maintained a &#8216;buy&#8217; on the stock with a target price of Rs 1,640 per share, seeing an upside of 10% from Thursday\u2019s trading price of Rs 1,491.&nbsp;<\/p><p>Motilal Oswal retained its \u2018buy\u2019 rating on the stock with a target of Rs 1,810, siting that Sun Pharma reported a slight miss at the operational level for Q4FY24 due to lower-than-expected sales in the Rest of the World(ROW) market and higher-than-expected operating expenses for the quarter.&nbsp;<\/p><p>Sun Pharmaceutical Industries Ltd., an international specialty pharmaceutical company, is actively enhancing its specialty pipeline in dermatology, ophthalmology, and onco-dermatology. According to a report by Motilal Oswal, the target action date of July 2024 is a significant near-term milestone for Deuruxolitinib.&nbsp;<\/p><p>Sun Pharma manufactures active pharmaceutical ingredients. Their branded products are commonly prescribed in chronic therapy areas such as cardiology, psychiatry, neurology, gastroenterology, diabetology, and respiratory.&nbsp;<\/p><p>The company also produces treatments for CNS disorders, cardiology, diabetes and metabolic disorders, gastroenterology, ophthalmology, oncology, pain, allergy, asthma, inflammation, and gynecology.&nbsp;<\/p><p>Sun Pharmaceutical shares have risen by 24% in the past six months and 60% in the past 12 months. The latest shareholding pattern reveals that company promoters hold a 54.48% stake, Foreign Institutional Investors hold 17.72%, and Domestic Institutional Investors hold 18.82%.<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written by Omkar Chitnis<\/strong><\/p><\/blockquote><h4 class=\"wp-block-heading\" id=\"h-disclaimer\"><strong>Disclaimer<\/strong><\/h4><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on <a href=\"http:\/\/tradebrains.in\/\">tradebrains.in<\/a> are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.<\/strong><\/p><div class=\"trade-after-content\" id=\"trade-3608440477\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>The shares of India&#8217;s largest drug manufacturer fell by 4.8% the day after the company announced robust 32% year-on-year growth in net profit.&nbsp; At 11:50 a.m., Sun Pharmaceutical Industries Ltd shares were trading at Rs 1,484 per share, down 3.66% on the National Stock Exchange from the previous close price. The company has a market [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":19569,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[4865,31],"tags":[948,936,3157,18464,7534,7535,18465],"class_list":["post-124723","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-analysis","category-news","tag-stock-market","tag-stock-market-news","tag-stock-to-watch","tag-sun-pharmaceutical-industries","tag-sun-pharmaceutical-industries-ltd-2","tag-sun-pharmaceutical-industries-ltd-share-price","tag-sun-pharmaceutical-industries-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>What to do with Sun Pharma shares post Q4 results? Here&#039;s everything you need to know - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"The shares of India&#039;s largest drug manufacturer fell by 4.8% the day after the company announced robust 32% year-on-year growth in net profit.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/what-to-do-with-sun-pharma-shares-post-q4-results-heres-everything-you-need-to-know\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"What to do with Sun Pharma shares post Q4 results? Here&#039;s everything you need to know\" \/>\n<meta property=\"og:description\" content=\"The shares of India&#039;s largest drug manufacturer fell by 4.8% the day after the company announced robust 32% year-on-year growth in net profit.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/what-to-do-with-sun-pharma-shares-post-q4-results-heres-everything-you-need-to-know\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-05-23T07:41:30+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-23T11:20:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/01\/Sun-Pharma-1-Cover-Image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/what-to-do-with-sun-pharma-shares-post-q4-results-heres-everything-you-need-to-know\/\",\"url\":\"https:\/\/tradebrains.in\/features\/what-to-do-with-sun-pharma-shares-post-q4-results-heres-everything-you-need-to-know\/\",\"name\":\"What to do with Sun Pharma shares post Q4 results? Here's everything you need to know - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/what-to-do-with-sun-pharma-shares-post-q4-results-heres-everything-you-need-to-know\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/what-to-do-with-sun-pharma-shares-post-q4-results-heres-everything-you-need-to-know\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/01\/Sun-Pharma-1-Cover-Image.jpg\",\"datePublished\":\"2024-05-23T07:41:30+00:00\",\"dateModified\":\"2024-05-23T11:20:17+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"The shares of India's largest drug manufacturer fell by 4.8% the day after the company announced robust 32% year-on-year growth in net profit.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/what-to-do-with-sun-pharma-shares-post-q4-results-heres-everything-you-need-to-know\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/what-to-do-with-sun-pharma-shares-post-q4-results-heres-everything-you-need-to-know\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/what-to-do-with-sun-pharma-shares-post-q4-results-heres-everything-you-need-to-know\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/01\/Sun-Pharma-1-Cover-Image.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/01\/Sun-Pharma-1-Cover-Image.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/what-to-do-with-sun-pharma-shares-post-q4-results-heres-everything-you-need-to-know\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"What to do with Sun Pharma shares post Q4 results? Here&#8217;s everything you need to know\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"What to do with Sun Pharma shares post Q4 results? Here's everything you need to know - Trade Brains Features","description":"The shares of India's largest drug manufacturer fell by 4.8% the day after the company announced robust 32% year-on-year growth in net profit.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/what-to-do-with-sun-pharma-shares-post-q4-results-heres-everything-you-need-to-know\/","og_locale":"en_US","og_type":"article","og_title":"What to do with Sun Pharma shares post Q4 results? Here's everything you need to know","og_description":"The shares of India's largest drug manufacturer fell by 4.8% the day after the company announced robust 32% year-on-year growth in net profit.\u00a0","og_url":"https:\/\/tradebrains.in\/features\/what-to-do-with-sun-pharma-shares-post-q4-results-heres-everything-you-need-to-know\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2024-05-23T07:41:30+00:00","article_modified_time":"2024-05-23T11:20:17+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/01\/Sun-Pharma-1-Cover-Image.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/what-to-do-with-sun-pharma-shares-post-q4-results-heres-everything-you-need-to-know\/","url":"https:\/\/tradebrains.in\/features\/what-to-do-with-sun-pharma-shares-post-q4-results-heres-everything-you-need-to-know\/","name":"What to do with Sun Pharma shares post Q4 results? Here's everything you need to know - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/what-to-do-with-sun-pharma-shares-post-q4-results-heres-everything-you-need-to-know\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/what-to-do-with-sun-pharma-shares-post-q4-results-heres-everything-you-need-to-know\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/01\/Sun-Pharma-1-Cover-Image.jpg","datePublished":"2024-05-23T07:41:30+00:00","dateModified":"2024-05-23T11:20:17+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"The shares of India's largest drug manufacturer fell by 4.8% the day after the company announced robust 32% year-on-year growth in net profit.\u00a0","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/what-to-do-with-sun-pharma-shares-post-q4-results-heres-everything-you-need-to-know\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/what-to-do-with-sun-pharma-shares-post-q4-results-heres-everything-you-need-to-know\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/what-to-do-with-sun-pharma-shares-post-q4-results-heres-everything-you-need-to-know\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/01\/Sun-Pharma-1-Cover-Image.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/01\/Sun-Pharma-1-Cover-Image.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/what-to-do-with-sun-pharma-shares-post-q4-results-heres-everything-you-need-to-know\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"What to do with Sun Pharma shares post Q4 results? Here&#8217;s everything you need to know"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/124723","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=124723"}],"version-history":[{"count":3,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/124723\/revisions"}],"predecessor-version":[{"id":124763,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/124723\/revisions\/124763"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/19569"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=124723"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=124723"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=124723"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}